Cryosite Limited (ASX:CTE – Get Free Report) insider Mark Kerr sold 154,494 shares of Cryosite stock in a transaction on Friday, June 21st. The stock was sold at an average price of A$1.05 ($0.70), for a total transaction of A$162,218.70 ($108,145.80).
Mark Kerr also recently made the following trade(s):
- On Tuesday, April 23rd, Mark Kerr bought 1,000,000 shares of Cryosite stock. The shares were purchased at an average cost of A$0.83 ($0.55) per share, with a total value of A$830,000.00 ($553,333.33).
Cryosite Price Performance
The company has a current ratio of 2.32, a quick ratio of 1.76 and a debt-to-equity ratio of 87.26.
Cryosite Company Profile
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries.
Featured Stories
- Five stocks we like better than Cryosite
- What is a Dividend King?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Russell 2000 Index, How Investors Use it For Profitable Trading
- MarketBeat Week in Review – 6/24 – 6/28
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Cryosite Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryosite and related companies with MarketBeat.com's FREE daily email newsletter.